ea0043oc8 | Cardiovascular Outcome Studies | WCTD2016
Mejia-Rodriguez Oliva
, Ruiz-Vega Humberto
, Alvarez-Aguilar Cleto
, Ceballos-Reyes Guillermo
, Galvan-Plata Maria Eugenia
, Paniagua Ramon
Background: Type 2 DM and chronic renal disease CKD are conditions associated with severe hypertension, loss of the blood pressure circadian rhythm (CR) and sympathetic nervous system (SNS) hyperactivity, suggesting a deficient dopaminergic modulation that could be reversed with dopamine agonists such as bromocriptine (BEC).Objective: The objective of this study was to evaluate the effect of bromocriptine in the blood pressure CR in patients with type 2 ...